In biostimulator procedures, a strategic approach rather than simple injection is becoming key to differentiation.
Biostimulators are treatments where components like PLLA, PCL, and CaHA induce collagen production in the body. Even with the same product, results can vary significantly depending on the dilution ratio, injection depth, injection volume, and treatment interval.
Director Kim Min-seung emphasized that biostimulator protocols should be designed by comprehensively considering the patient's skin thickness, degree of aging, and lifestyle patterns. Now, strategy formulation is more competitive than product selection.